LDL cholesterol (mmol/L), change from baseline · overweight and obese participants with T2DM (weight‐reducing phase only)
1 finding from 1 review
Constipation · overweight and obese participants with T2DM (weight‐reducing phase only)
It is very uncertain whether summary of findings table ‐ Low‐carbohydrate weight‐reducing diets changes constipation at 3 to < 12 months compared with balanced‐carbohydrate weight‐reducing diets (very low certainty).
1 finding from 1 review
Number of participants per group with weight loss of at least 5% at ≥ 12 months · overweight and obese participants without T2DM (weight‐reducing phase only)
It is very uncertain whether summary of findings table ‐ Low‐carbohydrate weight‐reducing diets changes number of participants per group with weight loss of at least 5% at… compared with balanced‐carbohydrate weight‐reducing diets (very low certainty).
1 finding from 1 review
Cardiovascular mortality ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase only)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in DBP (mmHg) at ≥ 12 months · overweight and obese participants without T2DM (weight‐reducing phase only)
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · overweight and obese participants without T2DM (weight‐reducing phase only)
1 finding from 1 review
Constipation · overweight and obese participants without T2DM (weight‐reducing phase only)
It is very uncertain whether summary of findings table ‐ Low‐carbohydrate weight‐reducing diets changes constipation at 3 to < 12 months compared with balanced‐carbohydrate weight‐reducing diets (very low certainty).
1 finding from 1 review
Hospital readmission · adults (aged greater than 18 years) with acute heart failure
Summary of findings table ‐ Continuous infusion of intravenous loop… showed no clear difference in readmission to hospital following discharge compared with bolus injection of intravenous loop diuretics (low certainty).
1 finding from 1 review
Adherence to antipsychotic medication: number of missed doses, average endpoint data, short term (up to 6 months) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… probably leads to higher medication adherence at ≤ 6 months compared with 'usual care' (moderate certainty).
1 finding from 1 review
Medication adherence (dichotomous) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… leads to higher medication adherence at > 6 months compared with 'usual care' (high certainty).
1 finding from 1 review
LDL‐C reduction (LDL‐C) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at ≤ 6 months (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at > 6 mos (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review